NO985699L - Enterisk belegg omfattende alginsyre, for et oralt preparat - Google Patents

Enterisk belegg omfattende alginsyre, for et oralt preparat

Info

Publication number
NO985699L
NO985699L NO985699A NO985699A NO985699L NO 985699 L NO985699 L NO 985699L NO 985699 A NO985699 A NO 985699A NO 985699 A NO985699 A NO 985699A NO 985699 L NO985699 L NO 985699L
Authority
NO
Norway
Prior art keywords
alginic acid
enteric coating
oral preparation
gelatine
pellet
Prior art date
Application number
NO985699A
Other languages
English (en)
Other versions
NO327294B1 (no
NO985699D0 (no
Inventor
Joern Marcussen
Erik Brandsborg
Original Assignee
Bifodan As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bifodan As filed Critical Bifodan As
Publication of NO985699D0 publication Critical patent/NO985699D0/no
Publication of NO985699L publication Critical patent/NO985699L/no
Publication of NO327294B1 publication Critical patent/NO327294B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Jellies, Jams, And Syrups (AREA)
NO19985699A 1996-06-06 1998-12-04 Sammensetning for dannelse av et enterisk belegg pa et oralt preparat, preparatet forsynt med et enterisk belegg og fremgangsmate for fremstilling av et slikt preparat. NO327294B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK63696 1996-06-06
PCT/DK1997/000252 WO1997046224A1 (en) 1996-06-06 1997-06-06 Enteric coating, comprising alginic acid, for an oral preparation

Publications (3)

Publication Number Publication Date
NO985699D0 NO985699D0 (no) 1998-12-04
NO985699L true NO985699L (no) 1999-02-08
NO327294B1 NO327294B1 (no) 2009-06-02

Family

ID=8095832

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19985699A NO327294B1 (no) 1996-06-06 1998-12-04 Sammensetning for dannelse av et enterisk belegg pa et oralt preparat, preparatet forsynt med et enterisk belegg og fremgangsmate for fremstilling av et slikt preparat.

Country Status (14)

Country Link
US (1) US6455052B1 (no)
EP (1) EP0952824B1 (no)
JP (1) JP2000514406A (no)
KR (1) KR20000016331A (no)
CN (1) CN1147291C (no)
AT (1) ATE277605T1 (no)
AU (1) AU717817B2 (no)
BR (1) BR9709535A (no)
CA (1) CA2257378C (no)
DE (1) DE69730991T2 (no)
IL (1) IL127378A (no)
NO (1) NO327294B1 (no)
NZ (1) NZ333182A (no)
WO (1) WO1997046224A1 (no)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3142821B2 (ja) * 1998-08-27 2001-03-07 株式会社エヌ・ティ・ティ・ドコモ 情報通信ネットワークの課金方法
JP3142820B2 (ja) * 1998-08-27 2001-03-07 株式会社エヌ・ティ・ティ・ドコモ プッシュ型情報配信方法およびその中継装置
AU2001296193B2 (en) * 2000-10-20 2006-04-27 Biovitrum Ab 2-, 3-, 4-, or 5-substituted-N1-(benzensulfonyl)indoles and their use in therapy
NL1018991C2 (nl) * 2001-09-20 2003-03-21 Tno Vochtwerende eetbare bekledingslaag voor voedingsmiddelen.
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
KR100491647B1 (ko) * 2002-11-21 2005-05-27 한국화학연구원 알긴산 나트륨 피복층을 포함하는 벤즈 이미다졸 유도체의경구체제 및 그의 제조방법
US7122370B2 (en) * 2003-01-14 2006-10-17 Randolph Stanley Porubcan Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
GB0320522D0 (en) * 2003-09-02 2003-10-01 Glaxo Group Ltd Formulation
ES2300546T3 (es) * 2003-09-05 2008-06-16 Myung-Jun Chung Polvo de bacterias del acido lactico doblemente recubiertas usando proteina y polisacarido y metodo de preparacion del mismo y forma farmaceutica del mismo.
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
WO2006012536A2 (en) 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
ATE515198T1 (de) 2005-05-18 2011-07-15 Dsm Ip Assets Bv Zusammensetzung für die enterale verabreichung von mikroorganismen
US8343548B2 (en) * 2006-08-08 2013-01-01 Shin-Etsu Chemical Co., Ltd. Solid dosage form comprising solid dispersion
US8519120B2 (en) 2006-08-08 2013-08-27 Shin-Etsu Chemical Co., Ltd. Methods for producing a low-substituted hydroxypropylcellulose powder
US8343547B2 (en) 2006-08-08 2013-01-01 Shin-Etsu Chemical Co., Ltd. Solid dosage form comprising solid dispersion
KR20180049197A (ko) 2008-09-17 2018-05-10 헌터 이뮤놀로지 리미티드 비피막형 헤모필루스 인플루엔자 백신 및 그의 용도
SG173832A1 (en) * 2009-02-24 2011-09-29 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
WO2011009602A1 (en) 2009-07-22 2011-01-27 Grünenthal GmbH Hot-melt extruded controlled release dosage form
TWI473628B (zh) 2009-07-22 2015-02-21 用於對氧化敏感之類鴉片藥劑之抗破壞劑型
EP2563372A4 (en) 2010-04-28 2013-10-02 Ritter Pharmaceuticals Inc PREBIOTIC FORMULATIONS AND METHODS OF USE
US8940858B2 (en) * 2010-05-17 2015-01-27 Northwestern University Fibrous microcapsules and methods of assembly and use thereof
CA2808219C (en) 2010-09-02 2019-05-14 Gruenenthal Gmbh Tamper resistant dosage form comprising inorganic salt
AU2012289764B2 (en) 2011-07-29 2017-03-02 Grünenthal GmbH Tamper-resistant tablet providing immediate drug release
ES2648129T3 (es) 2011-07-29 2017-12-28 Grünenthal GmbH Pastilla a prueba de manipulación que proporciona una liberación inmediata de un medicamento
PL2838512T3 (pl) 2012-04-18 2018-12-31 Grünenthal GmbH Farmaceutyczna postać dawkowania odporna na niewłaściwe użycie i odporna na uderzeniowe uwalnianie dawki
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
AU2014273227B2 (en) 2013-05-29 2019-08-15 Grunenthal Gmbh Tamper-resistant dosage form containing one or more particles
JP6449871B2 (ja) 2013-07-12 2019-01-09 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング エチレン−酢酸ビニルポリマーを含有する改変防止剤形
EP3073994A1 (en) 2013-11-26 2016-10-05 Grünenthal GmbH Preparation of a powdery pharmaceutical composition by means of cryo-milling
WO2015153841A1 (en) 2014-04-04 2015-10-08 Ritter Pharmaceuticals, Inc. Methods and compositions for microbiome alteration
EP3142646A1 (en) 2014-05-12 2017-03-22 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
WO2016035756A1 (ja) * 2014-09-03 2016-03-10 ライオン株式会社 コーティング製剤及びその製造方法
US11865099B2 (en) 2015-07-17 2024-01-09 Laboratori Baldacci S.P.A. Product based on iron bis-glycinate chelate and alginic acid and/or water-soluble salts thereof, formulations thereof, and pharmaceutical uses thereof
ITUB20152290A1 (it) * 2015-07-17 2017-01-17 Laboratori Baldacci Spa Prodotto a base di ferro bisglicinato chelato e acido alginico e/o suoi sali idrosolubili, sue formulazioni ed suoi usi farmaceutici
WO2017042325A1 (en) 2015-09-10 2017-03-16 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
CN115252650A (zh) 2015-11-03 2022-11-01 布里格姆及妇女医院股份有限公司 用于治疗和/或预防食物变态反应的治疗性微生物群
US20170296476A1 (en) * 2016-04-15 2017-10-19 Grünenthal GmbH Modified release abuse deterrent dosage forms
US10618042B1 (en) 2017-05-31 2020-04-14 University Of South Florida Mixed metal oxide extrudate catalyst
CA3088630A1 (en) 2017-12-15 2019-06-20 Solarea Bio, Inc. Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
FR3083545A1 (fr) 2018-07-04 2020-01-10 Institut National De La Recherche Agronomique Utilisation d'une souche de roseburia intestinalis pour la prevention et le traitement de l'inflammation de l'intestin
CA3111795A1 (en) 2018-09-05 2020-03-12 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases
US11980647B2 (en) 2018-09-05 2024-05-14 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
EP3646857A1 (en) 2018-11-01 2020-05-06 Evonik Operations GmbH Colonic delivery system for microorganisms
US11122828B2 (en) 2018-11-05 2021-09-21 MarvelBiome, Inc. Microbial compositions comprising ellagitannin and methods of use
CA3143713A1 (en) 2019-06-19 2020-12-24 Solarea Bio, Inc. Microbial compositions and methods for producing upgraded probiotic assemblages
WO2023006880A1 (en) * 2021-07-29 2023-02-02 Nutrition & Biosciences Usa 1, Llc Controlled release coating agent
EP4436407A1 (en) 2021-11-22 2024-10-02 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
US20230190834A1 (en) 2021-12-21 2023-06-22 Solarea Bio, Inc. Immunomodulatory compositions comprising microbial entities
WO2025064645A1 (en) 2023-09-19 2025-03-27 Flagship Pioneering Innovations Vi, Llc Compositions and methods for treating inflammatory bowel disease
WO2025064621A1 (en) 2023-09-19 2025-03-27 Flagship Pioneering Innovations Vi, Llc Compositions and methods for treating colorectal cancer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE338976B (no) * 1970-01-29 1971-09-27 Foerenade Superfosfatfab Ab
GB1509866A (en) * 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
CN1033441A (zh) * 1987-12-11 1989-06-21 福建省水产研究所 用褐藻胶制肠溶片剂的方法
CN1034489A (zh) * 1987-12-11 1989-08-09 福建省水产研究所 一种制作肠溶胶囊的方法
US5733575A (en) * 1994-10-07 1998-03-31 Bpsi Holdings, Inc. Enteric film coating compositions, method of coating therewith, and coated forms
US5674495A (en) * 1995-02-27 1997-10-07 Purdue Research Foundation Alginate-based vaccine compositions
EP0833617A1 (en) * 1995-06-20 1998-04-08 Pharma-Vinci A/S A method of preparing an oral preparation provided on the outer side with an enteric coating, as well as an oral preparation obtained by the method

Also Published As

Publication number Publication date
JP2000514406A (ja) 2000-10-31
EP0952824A1 (en) 1999-11-03
CA2257378C (en) 2009-04-07
AU717817B2 (en) 2000-04-06
CA2257378A1 (en) 1997-12-11
NO327294B1 (no) 2009-06-02
KR20000016331A (ko) 2000-03-25
IL127378A0 (en) 1999-10-28
BR9709535A (pt) 2000-01-11
EP0952824B1 (en) 2004-09-29
IL127378A (en) 2003-07-31
CN1223573A (zh) 1999-07-21
DE69730991D1 (de) 2004-11-04
ATE277605T1 (de) 2004-10-15
DE69730991T2 (de) 2006-02-23
CN1147291C (zh) 2004-04-28
AU3026397A (en) 1998-01-05
NZ333182A (en) 2000-03-27
WO1997046224A1 (en) 1997-12-11
US6455052B1 (en) 2002-09-24
NO985699D0 (no) 1998-12-04

Similar Documents

Publication Publication Date Title
NO985699L (no) Enterisk belegg omfattende alginsyre, for et oralt preparat
NO870558D0 (no) Fremgangsmaate for fremstilling av et langsomt frigivende farmasoeytisk preparat.
EA200401086A1 (ru) Жевательная резинка с покрытием, содержащая активное вещество системного действия
DK13491D0 (da) Anvendelse af et enzymholdigt granulat og fremgangsmaade til fremstilling af et forderstof i tabletform
IL109245A (en) Veterinary composition in the form of a pastelike gel containing enteric coated beads or tablets of a proton pump inhibitor compound
FI904482A7 (fi) Kumikoostumus, joka sisältää aktiivisia purukumin aineosia sisältäviä dispergoituja huokosia helmiä ja menetelmä
CA2300281A1 (fr) Compositions visqueuses aqueuses, limpides ou non, pour la fabrication de capsules molles et de capsules dures, et procede de fabrication de films pour de telles capsules
AU1380199A (en) Gelatine compositions
IS5526A (is) 11ß-Halógen-7alfa-setin estratríen, aðferð til framleiðslu á lyfjasamsetningum sem innihalda fyrrnefnd estratríen og notkun þeirra til framleiðslu á læknislyfjum
BR0103033A (pt) Partìculas farmacêuticas de sabor mascarado
KR880701543A (ko) 동물의 장구간에 생물학적 활성물질을 방출하는데 유용한 미세과립형 제제
PT1244472E (pt) Composicao vitaminica em particulas
EP0934004A4 (en) ENCAPSULATED AND COATED ACTIVE INGREDIENTS, CHEWING GUMS CONTAINING THEM AND PREPARATION METHODS THEREOF
PL344314A1 (en) Multiparticulate pharmaceutical form with programmed and timed release and preparation method
CA2339931A1 (en) Extended release acetaminophen
TR199802670T2 (xx) Pestisidal tablet form�lasyonlar�.
UA39899C2 (uk) Спосіб приготування сухого сипучого порошку ацифлуорфену або його агротехнічно придатних солей (варіанти), приготований таким способом сухий сипучий порошок (варіанти) та пва-пакет, що містить cухий сипучий порошок (варіанти)
DE69530298D1 (de) Mit agar-agar modifizierte gelatine enthaltender gelierender wirkstoff und diesen enthaltende lebensmittel
AU4823290A (en) Method and apparatus for identifying and/or dispensing medicinal treatment in the form of a substance, such as powder, paste or liquid, to a wild animal
JPH0247215B2 (no)
JPS54129130A (en) Method for promoting roughage digestion of animal
ES2164566A1 (es) Preparacion cosmetica o dermofarmaceutica compuesta de milicapsulas conrecubrimiento de polisacaridos cationicos.
WO2000001363A3 (en) Enteric coated pharmaceutical formulation
JPS5573608A (en) Stable diagnosing drug for radioactive technetium labeling
EP0123546A3 (en) Compositions for treating inflammation and eliciting analgesia

Legal Events

Date Code Title Description
MK1K Patent expired